These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17109244)

  • 1. [Proven and new parameters of hypertensive target organ damage].
    Schmidt BM; Schmieder RE
    Dtsch Med Wochenschr; 2006 Nov; 131(46 Spec No):H20-3. PubMed ID: 17109244
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardio-renal organ damage and cardiovascular outcomes in hypertension.
    Cuspidi C
    J Hypertens; 2009 Apr; 27(4):702-6. PubMed ID: 19300106
    [No Abstract]   [Full Text] [Related]  

  • 3. Global risk stratification in primary hypertension: the role of the kidney.
    Leoncini G; Ratto E; Viazzi F; Conti N; Falqui V; Parodi A; Tomolillo C; Deferrari G; Pontremoli R
    J Hypertens; 2008 Mar; 26(3):427-32. PubMed ID: 18300851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of silent cerebrovascular disease refines risk stratification of hypertensive patients.
    Henskens LH; van Oostenbrugge RJ; Kroon AA; Hofman PA; Lodder J; de Leeuw PW
    J Hypertens; 2009 Apr; 27(4):846-53. PubMed ID: 19300113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Organ and system involvement in arterial hypertension and its classification].
    da Costa JN
    Rev Port Cardiol; 1989 Oct; 8(10):671-4. PubMed ID: 2631815
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevalence and correlates of multiple organ damage in a never-treated hypertensive population: role of ambulatory blood pressure.
    Cuspidi C; Valerio C; Sala C; Esposito A; Masaidi M; Negri F; Zanchetti A; Mancia G
    Blood Press Monit; 2008 Feb; 13(1):7-13. PubMed ID: 18199918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unexpectedly high prevalence of target-organ damage in newly diagnosed Nigerians with hypertension.
    Salako BL; Ogah OS; Adebiyi AA; Adedapo KS; Bekibele CO; Oluleye TS; Okpechi I
    Cardiovasc J Afr; 2007; 18(2):77-83. PubMed ID: 17497043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac and renal damage in the elderly hypertensive.
    Ribstein J; Du Cailar G; Zanchetti A
    J Renin Angiotensin Aldosterone Syst; 2002 Sep; 3 Suppl 1():S16-24. PubMed ID: 12455558
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypertensive crisis and postcrisis management.
    Lowenthal DT
    Compr Ther; 1978 Dec; 4(12):32-9. PubMed ID: 738010
    [No Abstract]   [Full Text] [Related]  

  • 10. Blood pressure load, vascular permeability and target organ damage in primary hypertension.
    Falqui V; Viazzi F; Leoncini G; Ratto E; Parodi A; Conti N; Tomolillo C; Deferrari G; Pontremoli R
    J Nephrol; 2007; 20 Suppl 12():S63-7. PubMed ID: 18050146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical profile and management of hypertensive patients with chronic ischemic heart disease and renal dysfunction attended by cardiologists in daily clinical practice.
    Barrios V; Escobar C; Murga N; de Pablo C; Bertomeu V; Calderón A; Echarri R
    J Hypertens; 2008 Nov; 26(11):2230-5. PubMed ID: 18854765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of cardiovascular outcome by the estimated glomerular filtration rate and estimated creatinine clearance in the high-risk hypertension population of the VALUE trial.
    Maaravi Y; Bursztyn M; Stessman J
    J Hypertens; 2008 Jan; 26(1):154; author reply 154. PubMed ID: 18090555
    [No Abstract]   [Full Text] [Related]  

  • 13. Mild hyperuricemia and subclinical renal damage in untreated primary hypertension.
    Viazzi F; Leoncini G; Ratto E; Falqui V; Parodi A; Conti N; Derchi LE; Tomolillo C; Deferrari G; Pontremoli R
    Am J Hypertens; 2007 Dec; 20(12):1276-82. PubMed ID: 18047917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of cardiovascular outcome by estimated glomerular filtration rate and estimated creatinine clearance in the high-risk hypertension population of the VALUE trial.
    Ruilope LM; Zanchetti A; Julius S; McInnes GT; Segura J; Stolt P; Hua TA; Weber MA; Jamerson K;
    J Hypertens; 2007 Jul; 25(7):1473-9. PubMed ID: 17563571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Independent association of circulating resistin with glomerular filtration rate in the early stages of essential hypertension.
    Dimitriadis K; Tsioufis C; Selima M; Tsiachris D; Miliou A; Kasiakogias A; Andrikou E; Tousoulis D; Stefanadis C
    J Hum Hypertens; 2009 Oct; 23(10):668-73. PubMed ID: 19262583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hypertension: early detection of target organ damage].
    Heim A; Pasche A; Feihl F; Liaudet L; Waeber B
    Rev Med Suisse; 2007 Sep; 3(124):1996, 1999-2002. PubMed ID: 17955826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between obesity and chronic kidney disease in Japanese: differences in gender and hypertensive status?
    Ishizaka N; Ishizaka Y; Toda E; Koike K; Seki G; Nagai R; Yamakado M
    Hypertens Res; 2007 Nov; 30(11):1059-64. PubMed ID: 18250555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The heart, kidney, and brain as target organs in hypertension.
    Mensah GA; Croft JB; Giles WH
    Cardiol Clin; 2002 May; 20(2):225-47. PubMed ID: 12119798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homocysteinemia in hypertensive patients with renal target organ damage (mild renal dysfunction).
    Robles NR; Sanchez Munoz-Torrero JF; Garcia Gallego F; Velasco Gemio J; Escola JM
    Eur J Med Res; 2008 May; 13(5):196-9. PubMed ID: 18559300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Underestimation of renal risk in cardiology clinics. RICAR study].
    Martínez VB; González-Juanatey JR; Bertomeu-González V; Fácil L; Mazón P; Quiles J; Filozof C; Morillas P
    Nefrologia; 2008; 28(6):621-6. PubMed ID: 19016635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.